With growing interest in personalized medicine and precision healthcare, the exploration of novel biomarkers such as 11-Eicosenoic Acid holds promise for enhancing diagnostic accuracy and therapeutic efficacy.
11-Eicosenoic Acid, also known as gondoic acid, is a monounsaturated omega-9 fatty acid with a chain length of 20 carbons and one double bond located at the 11th carbon from the methyl end.
11-Eicosenoic acid is found in various nuts and plant oils. This type of fatty acid has an aliphatic tail that contains between 13 and 21 carbon atoms. Eicosenoic acid is not soluble in water and exhibits weak acidity.
Eicosenoic acid is not synthesized by humans but must be obtained through diet. Elevated levels of 11Z-Eicosenoic acid have been observed in the red blood cell membranes of children with regressive autism. [4.]
Otherwise, little research exists on the health benefits or toxicity of eicosenoic acid. [4.]
11-Eicosenoic acid is found in plant and nut oils, particularly jojoba oil. [4.]
The first step in laboratory testing for 11-Eicosenoic Acid involves sample collection from biological fluids, such as blood plasma or serum. Samples are typically obtained through venipuncture. Fasting is typically recommended to minimize variations in lipid composition due to dietary intake or circadian rhythms.
It is important to consult the laboratory company used for their recommended reference ranges. The level of eicosenoic acid present is often demonstrated as a percentage of an individual’s complete fatty acid profile, which includes omega-3, omega-6, and other omega-9 fatty acids, as well as saturated and trans-fatty acids.
Fatty acid test panels often include 11-eicosenoic acid under cis-Monounsaturated Omega-9 Fatty Acids for completeness, rather than to guide clinical decision-making. [7., 8.] There is little research to recommend increasing or decreasing 11-eicosenoic acid intake for health benefits. [4.]
A lipid panel assesses biomarkers such as total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides. Lipid panels are widely used in clinical practice to assess cardiovascular risk and lipid metabolism.
Elevated levels of LDL-C and triglycerides and reduced levels of HDL-C are associated with increased risk of atherosclerosis and cardiovascular diseases.
Integrating measurements of these lipid biomarkers with 11-Eicosenoic Acid levels provides a holistic view of lipid profile and cardiovascular risk.
Inflammation plays a crucial role in the pathogenesis of various diseases, including cardiovascular diseases, metabolic disorders, and autoimmune conditions. Biomarkers such as C-reactive protein (CRP) and high sensitivity CRP (hsCRP) are commonly used indicators of systemic inflammation.
Elevated levels of these biomarkers are associated with increased risk of chronic diseases and adverse health outcomes. Assessing inflammatory biomarkers alongside 11-Eicosenoic Acid levels helps identify individuals at higher risk of inflammation-related complications and guides therapeutic interventions.
Omega-3 Index Test
The Omega-3 Index test is a blood test that measures the percentage of omega-3 fatty acids (EPA and DHA) in the fatty membranes of red blood cells. This index is used to assess an individual's risk for heart disease and to gauge the adequacy of omega-3 intake in the diet. A higher Omega-3 Index is associated with a lower risk of sudden cardiac death and other adverse cardiovascular outcomes.
Omega-3 fatty acids are a group of essential polyunsaturated fats that play crucial roles in human physiology. They are vital for maintaining the structural integrity of cell membranes, supporting heart health, reducing inflammation, and facilitating neural development and function. [1., 3., 9.]
Research has highlighted their benefits in reducing the risk of heart disease, alleviating symptoms of arthritis, and promoting better mental health. [6.]
Omega-3s cannot be synthesized by the human body and must be obtained through diet. Rich natural sources include fatty fish like salmon, mackerel, and sardines, as well as flaxseeds, chia seeds, and walnuts.
Incorporating these foods into a balanced diet can help increase omega-3 levels naturally, offering significant health benefits.
Omega-6 Index Test
The Omega-6 Index test is a blood test that quantifies the amount of omega-6 fatty acids in your blood, specifically the red blood cell membranes. It is similar to the Omega-3 Index test, but focuses on the different group of polyunsaturated fatty acids.
This index provides insights into dietary intake of omega-6 fats, which are essential for human health but can become problematic in excessive amounts relative to omega-3 fatty acids.
Omega-6 fatty acids are a group of polyunsaturated fats essential for human health, playing a crucial role in brain function, normal growth, and development. They are primarily involved in the production of pro-inflammatory mediators, which are necessary for the immune response and cell signaling.
While omega-6 fatty acids support many bodily functions, an imbalance—particularly a high omega-6 to omega-3 ratio—can contribute to inflammation and increase the risk of chronic conditions such as heart disease and arthritis.
To optimize omega-6 levels, it is important to maintain a balanced diet that includes a variety of sources like nuts, seeds, and vegetable oils, while simultaneously increasing the intake of omega-3 fatty acids from sources like fish and flaxseeds to achieve a healthier fatty acid ratio.
The test is used to evaluate the balance of omega-6 to omega-3 fatty acids in the body, which can affect inflammation and overall cardiovascular health.
The Blood Sugar/Omega-3 and Omega-6 Index Connection [2.]
Alterations in omega-3 and omega-6 fatty acid indices can significantly impact hyperglycemia, a hallmark of diabetes. These polyunsaturated fatty acids (PUFAs) play crucial roles in regulating inflammation and insulin signaling pathways, which are often disrupted in diabetic conditions.
Typically, omega-3 fatty acids like eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are anti-inflammatory and can improve endothelial function and insulin sensitivity. Conversely, omega-6 fatty acids, primarily arachidonic acid (AA), although essential, can promote inflammatory pathways when overly abundant.
A balanced omega-6/omega-3 ratio is crucial as an elevated ratio may exacerbate inflammatory processes and contribute to vascular and beta-cell dysfunction, factors closely associated with the progression of diabetes and its complications.
Adjustments in dietary sources of these fatty acids, such as increased intake of omega-3-rich foods like fish and a managed intake of omega-6 from sources like vegetable oils, can help maintain a healthy fatty acid balance, thus potentially mitigating some of the metabolic disturbances seen in hyperglycemia.
Blood Sugar Assessment
Biomarkers for blood sugar health are essential tools for diagnosing and managing diabetes and pre-diabetic conditions. The primary biomarker is fasting blood glucose, which measures blood sugar levels after a period of fasting and indicates how well the body manages glucose without food intake.
Hemoglobin A1c (HbA1c) provides a longer-term view, reflecting average blood glucose levels over two to three months by measuring the percentage of glucose attached to hemoglobin.
Fructosamine, another important marker, offers a shorter-term view of glucose control, covering the previous two to three weeks.
For immediate, real-time glucose monitoring, especially in diabetes management, continuous glucose monitors (CGMs) measure glucose levels in the interstitial fluid at regular intervals, providing dynamic data on glucose trends throughout the day.
Click here to compare testing options for 11-Eicosenoic acid and order test panels.
[1.] Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, Ma J. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. The New England journal of medicine. 2002;346:1113-1118
[2.] Alfhili MA, Alsughayyir J, Basudan A, Alfaifi M, Awan ZA, Algethami MR, Al-Sheikh YA. Blood indices of omega-3 and omega-6 polyunsaturated fatty acids are altered in hyperglycemia. Saudi J Biol Sci. 2023 Mar;30(3):103577. doi: 10.1016/j.sjbs.2023.103577. Epub 2023 Jan 27. PMID: 36816730; PMCID: PMC9932443.
[3.] Block RC, Harris WS, Reid KJ, Sands SA, Spertus JA. EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls. Atherosclerosis. 2007;197:821-828
[4.] Farag MA, Gad MZ. Omega-9 fatty acids: potential roles in inflammation and cancer management. J Genet Eng Biotechnol. 2022 Mar 16;20(1):48. doi: 10.1186/s43141-022-00329-0. PMID: 35294666; PMCID: PMC8927560.
[5.] Human Metabolome Database: Showing metabocard for 11Z-Eicosenoic acid (HMDB0002231). hmdb.ca. Accessed April 15, 2024. https://hmdb.ca/metabolites/HMDB0002231
[6.] McNamara RK, Welge JA. Meta-analysis of erythrocyte polyunsaturated fatty acid biostatus in bipolar disorder. Bipolar disorders. 2016;18:300-306
[7.] Omega-3 Index Complete Sample Report.pdf. Google Docs. Accessed April 15, 2024. https://drive.google.com/file/d/1H315g2fZ9yCACMcPKtF0rWBL-S7HPvY3/view
[8.] Omega-3 Index Sample Report.pdf. Google Docs. Accessed April 15, 2024. https://drive.google.com/file/d/1kIEIZf5TvEU0CmLR709JLhHABHqL6pNq/view
[9.] Siscovick DS, Raghunathan TE, King I, Weinmann S, Wicklund KG, Albright J, Bovbjerg V, Arbogast P, Smith H, Kushi LH, et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA. 1995;274:1363-1367